Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.
Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.
Not yet recruiting · NCT06646445 · Registry updated 2025-06-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study. | Digestive System Diseases, Digestive System Neoplasms, Genomic Instability, Microsatellite Instability, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, mismatch repair cancer syndrome 1, neoplasm | Not yet recruiting | Phase 2 | 2025-06-13 | NCT06646445 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondation ARCAD | 3 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 25 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Leon Berard | Lyon | France | 34 |
| CHU Besançon | Besançon | France | 32 |
| CHU Bordeaux Haut Lévêque | Pessac | France | 1 |
| CHU Poitiers | Poitiers | France | 70 |
| CHU Toulouse | Toulouse | France | 76 |
| Groupe Hospitalier Diaconesses Croix Saint Simon | Paris | France | 6 |
| Hôpital Saint Antoine | Paris | France | 21 |
| IHFB Cognacq Jay | Levallois-Perret | France | 1 |
| Institut Mutualiste Montsouris | Paris | France | 29 |
| Institut Sainte Catherine | Avignon | France | 16 |